Nakamura, Sachie
Osaka, Hitoshi http://orcid.org/0000-0002-1320-1165
Muramatsu, Shin-ichi http://orcid.org/0000-0002-3185-7790
Takino, Naomi
Ito, Mika
Jimbo, Eriko F.
Watanabe, Chika
Hishikawa, Shuji
Nakajima, Takeshi
Yamagata, Takanori
Article History
Received: 1 July 2020
Revised: 21 September 2020
Accepted: 1 October 2020
First Online: 19 October 2020
Conflict of Interest
: SM owns equity in a gene therapy company (Gene Therapy Research Institution) that commercializes the use of AAV vectors for gene therapy applications. To the extent that the work in this manuscript may increase the value of these commercial holdings, SM has a potential conflict of interest.